News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
Australian OGTR: DIR 094 - Limited and controlled release of wheat and barley genetically modified for enhanced nutrient utilisation efficiency

.

Australia
February 10, 2009

DIR 094 - Limited and controlled release of wheat and barley genetically modified for enhanced nutrient utilisation efficiency
DIR 094 - Notification of Licence application - Limited and controlled release of wheat and barley genetically modified for enhanced nutrient utilisation efficiency - posted 10 February 2009 (PDF 47 KB)

NOTIFICATION OF APPLICATION

Receipt of licence application from CSIRO for dealings involving intentional release of genetically modified wheat and barley: DIR 094

Application

The Office of the Gene Technology Regulator (OGTR) has received a licence application (DIR 094) from CSIRO for an intentional release of genetically modified (GM) wheat and barley into the Australian environment which qualifies as a limited and controlled release under section 50A of the Gene Technology Act 2000 (the Act).

CSIRO is seeking approval to conduct a field trial of seventeen wheat lines and ten barley lines that have been genetically modified to improve the plants’ ability to utilise nutrients from the soil. The release is proposed to take place at one site at a CSIRO research facility in the Australian Capital Territory on a maximum area of 1 ha between July 2009 and June 2012.

No plant materials from the GM wheat and barley would be used for human food or animal feed.

Purpose of this notification

A comprehensive Risk Assessment and Risk Management Plan (RARMP) for the application is currently being prepared. I expect this to be released for public comment and advice from a broad range of experts, agencies and authorities in May 2009. The Act specifies a 30 day minimum consultation period if no significant risks to human health and safety or the environment are identified, and a 50 day minimum consultation period if significant risks are identified.

In the interim, you can obtain a copy of the application itself by contacting my Office (see contact details below, please quote the reference number DIR 094). As the application is quite lengthy, you may prefer to view a summary of the application, which is posted on our website along with this document (under ‘What’s New’). If you would like to receive a hard copy of the application summary, please contact us and we will post it to you.

If you have questions about the application, or how you can provide comment, please contact the OGTR at:
The Office of the Gene Technology Regulator, MDP 54, GPO Box 9848, Canberra, ACT, 2601 (http://www.ogtr.gov.au)
Telephone: 1800 181 030 Facsimile: 02 6271 4202 E-mail: ogtr@health.gov.au
Website http://www.ogtr.gov.au

DIR 094 - Licence application summary (PDF 75 KB)

 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved